News and Events
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read MoreClinical trial researches CAR T-cell therapy for hairy cell leukemia
Robert J. Kreitman, M.D., Senior Investigator in the Laboratory of Molecular Biology, is leading a study to see whether CAR T-cell therapy impacts patients with hairy cell leukemia.
Read MoreClinical trials research immunotherapy for Kaposi sarcoma
Clinical trials led by Ramya Ramaswami, M.B.B.S., M.P.H., Physician-Scientist Early Investigator in the HIV and AIDS Malignancy Branch, are researching immunotherapy for Kaposi sarcoma.
Read MoreIn Memoriam: Joost J. Oppenheim, M.D. (1934–2022)
The CCR mourns the recent passing of colleague and friend Joost Oppenheim, M.D., Senior Investigator and Head of the Cellular Immunology Section in the Cancer Innovation Laboratory.
Read MoreFour CCR researchers receive high honors
CCR Senior Investigators Michael Lichten, Ph.D., Deborah Morrison, Ph.D., Mary Carrington, Ph.D, and Susan Lea, D.Phil., F.Med.Sci., have been elected to notable scientific academies and societies in recognition of their significant and impactful research accomplishments.
Read MoreElaine S. Jaffe receives HHS Career Achievement Award
Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, was awarded a 2022 Career Achievement Award by the Department of Health and Human Services in recognition of her groundbreaking advances in the diagnosis and treatment of patients with blood cancers.
Read MoreClinical trial researching PSMA imaging in prostate cancer
A clinical trial led by Deborah E. Citrin, M.D., Senior Investigator in the Radiation Oncology Branch, is researching prostate-specific membrane antigen (PSMA) imaging to evaluate response to radiation treatment in patients with prostate cancer.
Read MoreComputational model finds signatures of T cell resilience in solid tumors
Evaluating T cell resilience can help researchers predict — and possibly improve — immunotherapy outcomes.
Read MoreClinical trial researching therapy for some small cell lung cancers
Anish Thomas, M.B.B.S., M.D., Lasker Clinical Research Scholar in the Developmental Therapeutics Branch, is leading NCI’s participation in a trial researching therapies for small cell lung cancer.
Read MoreAligned Blog: A for Accessibility
You’ve likely heard the phrase “diversity, equity and inclusion” numerous times, but more and more you may hear “accessibility” as well. What is meant by “accessibility” and why call it out separately from diversity, equity and inclusion?
Read MoreKandice Tanner receives Arthur S. Flemming Award
Kandice Tanner, Ph.D., a Senior Investigator in the Laboratory of Cell Biology, is a recipient of the 2021 Arthur S. Flemming Awards, which honor the accomplishments of midcareer federal employees. Dr. Tanner received the award for her breakthrough discovery that patterns of cancer spread in humans can be recreated in zebrafish. This novel animal model allows researchers to address organ-specific drug responses and develop effective immunotherapies in a preclinical platform.
Read More